BROADWOOD CAPITAL INC - ONCOCYTE CORP ownership

ONCOCYTE CORP's ticker is OCX and the CUSIP is 68235C107. A total of 60 filers reported holding ONCOCYTE CORP in Q4 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
BROADWOOD CAPITAL INC ownership history of ONCOCYTE CORP
ValueSharesWeighting
Q2 2023$11,541,707
+39.5%
50,181,335
+114.9%
0.86%
+48.3%
Q1 2023$8,276,550
+10.4%
23,353,6970.0%0.58%
-7.2%
Q4 2022$7,494,201
-56.0%
23,353,6970.0%0.63%
-51.8%
Q3 2022$17,048,000
-18.9%
23,353,6970.0%1.30%
-17.9%
Q2 2022$21,011,000
-18.7%
23,353,697
+34.6%
1.58%
-15.0%
Q1 2022$25,851,000
-31.3%
17,349,9450.0%1.86%
-19.4%
Q4 2021$37,649,000
-39.0%
17,349,9450.0%2.31%
-26.6%
Q3 2021$61,766,000
-35.9%
17,349,945
+3.4%
3.15%
-26.8%
Q2 2021$96,297,000
+10.6%
16,776,4840.0%4.30%
-7.0%
Q1 2021$87,070,000
+147.6%
16,776,484
+14.0%
4.63%
+121.9%
Q4 2020$35,172,000
+71.9%
14,716,2040.0%2.09%
+29.6%
Q3 2020$20,456,000
-27.2%
14,716,2040.0%1.61%
-26.8%
Q2 2020$28,108,000
-16.1%
14,716,204
+7.7%
2.20%
-43.9%
Q1 2020$33,482,000
+21.2%
13,666,204
+11.3%
3.91%
+22.9%
Q4 2019$27,618,000
+18.5%
12,274,738
+10.6%
3.18%
-1.5%
Q3 2019$23,306,000
+15.6%
11,098,267
+37.0%
3.24%
+28.3%
Q2 2019$20,165,000
-37.0%
8,098,2670.0%2.52%
-35.6%
Q1 2019$31,988,000
+206.4%
8,098,267
+7.1%
3.92%
+167.4%
Q4 2018$10,440,000
-44.8%
7,564,9340.0%1.46%
-16.6%
Q3 2018$18,912,000
-2.0%
7,564,9340.0%1.76%
-20.7%
Q2 2018$19,291,000
+21.4%
7,564,9340.0%2.22%
-4.0%
Q1 2018$15,886,000
-5.0%
7,564,934
+110.3%
2.31%
-1.0%
Q4 2017$16,725,000
-38.4%
3,596,6800.0%2.33%
-48.2%
Q3 2017$27,155,000
+70.8%
3,596,680
+17.7%
4.50%
+53.9%
Q2 2017$15,895,000
-12.6%
3,056,6800.0%2.92%
-15.7%
Q1 2017$18,187,000
-2.0%
3,056,680
+16.1%
3.47%
+10.3%
Q4 2016$18,553,000
+39.9%
2,631,6800.0%3.14%
+38.5%
Q3 2016$13,264,000
+240.8%
2,631,680
+140.7%
2.27%
+201.9%
Q2 2016$3,892,000
-22.8%
1,093,2190.0%0.75%
-28.0%
Q1 2016$5,040,000
-26.2%
1,093,2190.0%1.04%
-9.3%
Q4 2015$6,833,0001,093,2191.15%
Other shareholders
ONCOCYTE CORP shareholders Q4 2022
NameSharesValueWeighting ↓
BROADWOOD CAPITAL INC 14,716,204$20,456,0001.61%
PURA VIDA INVESTMENTS, LLC 6,022,534$8,371,0000.43%
P.A.W. CAPITAL CORP 199,700$278,0000.30%
Penbrook Management LLC 229,425$319,0000.28%
PERKINS CAPITAL MANAGEMENT INC 39,725$55,0000.05%
GSA CAPITAL PARTNERS LLP 201,047$279,0000.05%
Private Wealth Partners, LLC 150,000$209,0000.02%
Phoenix Holdings Ltd. 317,138$426,0000.02%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 255,300$355,0000.01%
ETF MANAGERS GROUP, LLC 157,933$226,0000.01%
View complete list of ONCOCYTE CORP shareholders